Panel Agrees With Lower Court: Cancer Fighting Patent Is Valid

Mealey's (May 15, 2019, 11:51 AM EDT) -- WASHINGTON, D.C. — A patented method of using the compound everolimus to treat advanced renal cell carcinoma (RCC) was confirmed as valid May 13 by the Federal Circuit U.S. Court of...
To view the full article, register now.